Onconova Therapeutics, Inc.·4

Apr 8, 7:19 PM ET

Maniar Manoj 4

4 · Onconova Therapeutics, Inc. · Filed Apr 8, 2019

Insider Transaction Report

Form 4
Period: 2018-12-12
Maniar Manoj
SVP - Product Development
Transactions
  • Award

    Stock Option (right to purchase)

    2018-12-12+5,0005,000 total
    Exercise: $3.41From: 2019-12-12Exp: 2028-12-12Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]These options vest 100% on the first anniversary of the grant date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -